In Vitro Cross-Resistance Profile of Nucleoside Reverse Transcriptase Inhibitor (NRTI) BMS-986001 against Known NRTI Resistance Mutations

Benzer Materyaller

• Activity of the HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068, against CD4-Independent Viruses and HIV-1 Envelopes Resistant to Other Entry Inhibitors
  Yazar:: Li, Zhufang, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1
  Yazar:: Smith, Robert A., ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• BMS-986001, an HIV Nucleoside Reverse Transcriptase Inhibitor, Does Not Degrade Mitochondrial DNA in Long-Term Primary Cultures of Cells Isolated from Human Kidney, Muscle, and Adipose Tissue
  Yazar:: Wang, Faye, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection
  Yazar:: Cruciani, Mario, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Ultra-Deep Pyrosequencing of Hepatitis B Virus Quasispecies from Nucleoside and Nucleotide Reverse-Transcriptase Inhibitor (NRTI)–Treated Patients and NRTI-Naive Patients
  Yazar:: Margeridon-Thermet, Severine, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)